Benjamin Shepherd is a recognized exchange-traded fund (ETF), mutual fund and stock expert with an extensive background analyzing time-tested funds, including their managers and strategies. Ben looks for investments that have proven themselves in both bull and bear markets. Ben also specializes in covering emerging markets, pinpointing the most dynamic investments in developing nations for market-beating growth.
Ben is chief investment strategist of Global Investment Strategist, which examines top-performing investments in Brazil, Russia, India, China, Japan, Indonesia, South Korea, and other rising economic powers. He’s also chief investment strategist of Benjamin Shepherd’s Wall Street, born from his years learning from famed investment guru Louis Rukeyser and subsequently serving as editor of Louis Rukeyser’s Wall Street and Louis Rukeyser’s Mutual Funds. In July 2013 Ben launched the Inflation Survival Letter, which guides investors on positioning themselves now for inflation’s inevitable arrival.
Along with these duties, Ben finds time to regularly contribute to Personal Finance, Investing Daily’s flagship product.
Did you miss the first Coca-Cola? The first McDonalds? Apple’s IPO? Here’s your second chance. From Eastern Europe to the Pacific Rim to South America – new markets are buoying investor profits. These are multiple market opportunities – new industrial giants, pharmaceuticals, and high-tech. Plus moneyed new consumers with any eye to buy every gadget – from phones to refrigerators – that have long been staples in our own society. For investors, it’s a once-in-a-lifetime ground-floor opportunity to profit from the birth of new economies. Learn More
Don’t let your wealth erode – lock in investments that will thrive as inflation spirals up! Learn More
Personal Finance is your one-stop source for market-beating investing advice. Philip Springer scours the world for the best investments – whether it be a stock, bond, MLP or commodity – to build and protect your wealth no matter what the “market” does. Get in-depth insight and analysis that cuts through the noise and hype to reveal the truth about the economy, the market and your investments. In today’s challenging market, let our 39 years of proven, battle-tested experience show you the smartest path to profits. Learn More
Louis Rukeyser left us years ago, but his protégé, Benjamin Shepherd, continues the tradition of Lou’s solid investing strategies. Join Ben as he locks in profits year after year. Learn More
As 2013 comes to a close, investors could easily call it the “Year of Water” — or a lack thereof.
This medical product distribution company occupies a “sweet spot” in the health care sector.
Recent positive economic moves by the Irish government underscore the increasing attractiveness of investing in Europe.
Although dramatic from a geopolitical standpoint, recent events concerning Iran will have little impact on inflation.
This Australia-based provider of medical care is positioned to get a big lift from demographic and budgetary trends in the country.
As emerging markets encounter challenges, investors can look even further afield on the globe for outsized gains.
The search for safer painkillers with lower potential for abuse is generating profits for this pharmaceutical innovator.
Janet Yellen’s prescription for growth is the monetary medicine we’ve already been taking for more than a year.
Global investors should monitor the current volatility of emerging market currencies, but not get spooked by it.
This undervalued company is positioned to profit from the growing reliance on hospice care.